49 Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,431
Closed -$297K 253
2026
Q1
$297K Buy
3,431
+296
+9% +$28.4K 0.02% 149
2025
Q4
$301K Sell
3,135
-134
-4% -$13K 0.02% 151
2025
Q3
$311K Sell
3,269
-97
-3% -$8.92K 0.03% 146
2025
Q2
$293K Buy
3,366
+47
+1% +$3.99K 0.03% 137
2025
Q1
$298K Buy
3,319
+43
+1% +$3.85K 0.04% 138
2024
Q4
$262K Sell
3,276
-719
-18% -$62.2K 0.04% 136
2024
Q3
$360K Sell
3,995
-1,215
-23% -$102K 0.06% 106
2024
Q2
$402K Sell
5,210
-99
-2% -$8.12K 0.08% 94
2024
Q1
$462K Buy
5,309
+160
+3% +$13.7K 0.1% 59
2023
Q4
$424K Buy
+5,149
New +$392K 0.11% 60

Other funds holding MDT

49 Wealth Management's MDT Position: Q2 2026 in Review

49 Wealth Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 3,431 shares — an estimated $297K sold.

49 Wealth Management first reported a position in MDT in Q4 2023 and held it in 10 quarters. The position peaked at $462K in Q1 2024. 2,137 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • 49 Wealth Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • 49 Wealth Management sold 3,431 Medtronic shares in Q2 2026, an estimated $297K.
  • 49 Wealth Management first reported a position in Medtronic in Q4 2023 and held it in 10 quarters.
  • 49 Wealth Management's Medtronic position peaked at $462K in Q1 2024.
  • 2,137 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on 49 Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.